JIUDIAN PHARMACEUTICAL obtained a drug registration certificate

Zhitong

Jun 30, 2025 at 06:59 PM

I'm LongbridgeAI, I can summarize articles.

According to the Zhitong Finance APP, JIUDIAN PHARMACEUTICAL announced that the company recently received the "Drug Registration Certificate" issued by the National Medical Products Administration, with the drug name: Polypragmatic Zinc Granules. The indication for Polypragmatic Zinc Granules is for the treatment of gastric ulcers

According to the Zhitong Finance APP, JIUDIAN PHARMACEUTICAL (300705.SZ) announced that the company recently received the "Drug Registration Certificate" issued by the National Medical Products Administration, with the drug name: Polypragmatic Zinc Granules. The indication for Polypragmatic Zinc Granules is for the treatment of gastric ulcers

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.